BioSpace News Archive

New data to address the treatment duration potential of first-in-class sustained release biodegradable implant

Alkahest, Inc. will present the results from its open label study evaluating AKST4290 for the treatment of wet age-related macular degeneration in treatment-naïve patients at the Retina World Congress in Fort Lauderdale, Florida on March 24, 2019 at 11:33 a.m. EST.

ESSA Pharma Inc., a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be attending the 31st Annual ROTH Conference to be held on March 17 -19 at the Ritz Carlton Laguna Niguel in Dana Point, California.

X. Sherry Liu, Ph.D., was presented with the Kappa Delta Young Investigator Award at the 2019 Annual Meeting of the American Academy of Orthopaedic Surgeons for her research into how a woman’s reproductive history is a key factor for osteoporosis and fracture risk due to estrogen deficiency.

Shoulder Innovations is pleased to announce the successful first human use of its new InSet Humeral short stem system.

New Research Reveals Disconnect Every Parent Needs to Know

Reference is made to the stock exchange notice on 6 March 2019 where Nordic Nanovector ASA announced the final result of the repair offering, in which 69,051 shares, each with a nominal value of NOK 0.20, at a subscription price of NOK 45.00 were allocated.

Venovo™ Venous Stent proven safe and effective in iliac and femoral veins

A new, single center retrospective study of glaucoma surgery patients published in the January 2019 issue of Clinical Ophthalmology shows that ab-interno trabeculotomy using one of Sight Sciences’ OMNI® Surgical System’s Predicate Devices provides a favorable safety profile and substantial long-term reductions in both intraocular pressure and IOP-lowering medications.

Ido Dor, CEO of Lavie Bio, will participate in a panel on Ag-Biologicals; in addition, Eran Kosover, CEO of AgPlenus will host a round table on collaborations in the field [14-March-2019] REHOVOT, Israel , March 1 4 , 2019 /PRNewswire/ -- - Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company devel